comparemela.com

Latest Breaking News On - Other otc silo - Page 1 : comparemela.com

Silo Pharma Announces Positive Results in Subcutaneous

ENGLEWOOD CLIFFS, N.J, July 12, 2022 (GLOBE NEWSWIRE) Silo Pharma, Inc . (OTCQB: SILO), a development-stage biopharmaceutical company today announces.

Eric-weisblum
Brett-maas
Silo-pharma-inc
Silo-pharma
Private-securities-litigation-reform-act
Relations-contact
Other-otc-silo
Silo-pharma
Nc

Silo Pharma Announces Successful Dosing of Patients

Study is examining effects of Psilocybin on Inflammatory MarkersENGLEWOOD CLIFFS, N.J., May 19, 2022 (GLOBE NEWSWIRE) Silo Pharma, Inc . (OTCQB:.

Eric-weisblum
Brett-maas
University-of-california-san-francisco
Translational-psychedelic-research-trpr-program
Silo-pharma-inc
Silo-pharma
California-san-francisco
Translational-psychedelic-research
Forward-looking-statements
Private-securities-litigation-reform-act
Relations-contact
Other-otc-silo

Silo Pharma Produces SPU-21 Liposomes for Rheumatoid

SPU-21 has shown Anti-arthritic activity for therapeutic use in preclinical studies..

Eric-weisblum
Brett-maas
Silo-pharma-inc
Frontage-laboratories
Silo-pharma
Rheumatoid-arthritis
Private-securities-litigation-reform-act
Relations-contact
Other-otc-silo
Silo-pharma
Nc

Silo Pharma Enters into Agreement with Contract Research

IND Enabling Study to prepare Silo Pharma Homing Peptides for Clinic.

California
United-states
Los-angeles
Eric-weisblum
Brett-maas
Corporate-communications
Silo-pharma-inc
Frontage-laboratories
Pharmacokinetic-study
Silo-pharma
Central-nervous-system-peptide
Joint-homing-peptide

Silo Pharma Announces Grant of U.S. Patent For its Novel

U.S. Patent and Trademark Office issued US Patent No. .

Eric-weisblum
Brett-maas
University-maryland-baltimore
Silo-pharma-inc
Englewood-cliffs
Silo-pharma
Chief-executive-officer
Private-securities-litigation-reform-act
Relations-contact
Other-otc-silo
Silo-pharma
Nc

vimarsana © 2020. All Rights Reserved.